Annual EBIT
-$66.08 M
-$7.74 M-13.27%
30 June 2022
Summary:
Applied Genetic Technologies annual earnings before interest & taxes is currently -$66.08 million, with the most recent change of -$7.74 million (-13.27%) on 30 June 2022. During the last 3 years, it has fallen by -$7.74 million (-13.27%).AGTC EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$17.68 M
-$32.00 K-0.18%
30 September 2022
Summary:
Applied Genetic Technologies quarterly earnings before interest & taxes is currently -$17.68 million, with the most recent change of -$32.00 thousand (-0.18%) on 30 September 2022.AGTC Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$67.33 M
-$1.26 M-1.91%
30 September 2022
Summary:
Applied Genetic Technologies TTM earnings before interest & taxes is currently -$67.33 million, with the most recent change of -$1.26 million (-1.91%) on 30 September 2022.AGTC TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AGTC EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -13.3% | -7.7% | -12.7% |
| 5 y5 years | -1419.0% | -53.1% | -304.4% |
AGTC EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -2448.1% | -260.6% | -740.5% |
Applied Genetic Technologies EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$17.68 M(+0.2%) | -$67.33 M(+1.9%) |
| June 2022 | -$66.08 M(+13.3%) | -$17.65 M(+30.0%) | -$66.08 M(+6.2%) |
| Mar 2022 | - | -$13.57 M(-26.4%) | -$62.21 M(-1.4%) |
| Dec 2021 | - | -$18.44 M(+12.3%) | -$63.11 M(+5.6%) |
| Sept 2021 | - | -$16.42 M(+19.2%) | -$59.76 M(+2.4%) |
| June 2021 | -$58.34 M(+27.5%) | -$13.78 M(-4.8%) | -$58.34 M(-1.2%) |
| Mar 2021 | - | -$14.47 M(-4.1%) | -$59.02 M(+6.0%) |
| Dec 2020 | - | -$15.09 M(+0.6%) | -$55.70 M(+13.2%) |
| Sept 2020 | - | -$15.00 M(+3.7%) | -$49.20 M(+7.5%) |
| June 2020 | -$45.75 M(+951.7%) | -$14.46 M(+29.6%) | -$45.75 M(+7.1%) |
| Mar 2020 | - | -$11.15 M(+29.8%) | -$42.73 M(+107.7%) |
| Dec 2019 | - | -$8.59 M(-25.6%) | -$20.57 M(+23.6%) |
| Sept 2019 | - | -$11.54 M(+0.9%) | -$16.65 M(+329.2%) |
| June 2019 | -$4.35 M(-80.6%) | -$11.44 M(-204.0%) | -$3.88 M(-596.0%) |
| Mar 2019 | - | $11.01 M(-335.6%) | $782.00 K(-104.4%) |
| Dec 2018 | - | -$4.67 M(-480.7%) | -$17.92 M(-8.1%) |
| Sept 2018 | - | $1.23 M(-118.1%) | -$19.49 M(-12.9%) |
| June 2018 | -$22.38 M(-1276.9%) | -$6.78 M(-11.9%) | -$22.38 M(+21.6%) |
| Mar 2018 | - | -$7.70 M(+23.3%) | -$18.41 M(+59.4%) |
| Dec 2017 | - | -$6.24 M(+274.4%) | -$11.55 M(+266.1%) |
| Sept 2017 | - | -$1.67 M(-40.5%) | -$3.15 M(-265.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | $1.90 M(-191.0%) | -$2.80 M(+235.3%) | $1.90 M(-73.6%) |
| Mar 2017 | - | -$836.00 K(-138.8%) | $7.19 M(-26.6%) |
| Dec 2016 | - | $2.15 M(-36.5%) | $9.79 M(-6.8%) |
| Sept 2016 | - | $3.39 M(+36.3%) | $10.51 M(-603.3%) |
| June 2016 | -$2.09 M(-91.5%) | $2.49 M(+40.7%) | -$2.09 M(-83.4%) |
| Mar 2016 | - | $1.77 M(-38.4%) | -$12.61 M(-39.3%) |
| Dec 2015 | - | $2.87 M(-131.2%) | -$20.76 M(-26.7%) |
| Sept 2015 | - | -$9.21 M(+14.7%) | -$28.34 M(+15.5%) |
| June 2015 | -$24.53 M(+95.4%) | -$8.03 M(+25.6%) | -$24.53 M(+17.2%) |
| Mar 2015 | - | -$6.39 M(+35.9%) | -$20.93 M(+17.6%) |
| Dec 2014 | - | -$4.70 M(-13.1%) | -$17.80 M(+11.2%) |
| Sept 2014 | - | -$5.41 M(+22.2%) | -$16.00 M(+27.4%) |
| June 2014 | -$12.56 M(+161.6%) | -$4.42 M(+35.7%) | -$12.56 M(+31.6%) |
| Mar 2014 | - | -$3.26 M(+12.2%) | -$9.54 M(+21.0%) |
| Dec 2013 | - | -$2.90 M(+47.8%) | -$7.88 M(+27.0%) |
| Sept 2013 | - | -$1.97 M(+39.5%) | -$6.21 M(+29.3%) |
| June 2013 | -$4.80 M(+158.7%) | -$1.41 M(-12.0%) | -$4.80 M(+41.6%) |
| Mar 2013 | - | -$1.60 M(+30.5%) | -$3.39 M(+89.6%) |
| Dec 2012 | - | -$1.23 M(+119.3%) | -$1.79 M(+219.3%) |
| Sept 2012 | - | -$560.00 K | -$560.00 K |
| June 2012 | -$1.85 M | - | - |
FAQ
- What is Applied Genetic Technologies annual earnings before interest & taxes?
- What is the all time high annual EBIT for Applied Genetic Technologies?
- What is Applied Genetic Technologies quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Applied Genetic Technologies?
- What is Applied Genetic Technologies TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Applied Genetic Technologies?
What is Applied Genetic Technologies annual earnings before interest & taxes?
The current annual EBIT of AGTC is -$66.08 M
What is the all time high annual EBIT for Applied Genetic Technologies?
Applied Genetic Technologies all-time high annual earnings before interest & taxes is $2.81 M
What is Applied Genetic Technologies quarterly earnings before interest & taxes?
The current quarterly EBIT of AGTC is -$17.68 M
What is the all time high quarterly EBIT for Applied Genetic Technologies?
Applied Genetic Technologies all-time high quarterly earnings before interest & taxes is $11.01 M
What is Applied Genetic Technologies TTM earnings before interest & taxes?
The current TTM EBIT of AGTC is -$67.33 M
What is the all time high TTM EBIT for Applied Genetic Technologies?
Applied Genetic Technologies all-time high TTM earnings before interest & taxes is $10.51 M